192 related articles for article (PubMed ID: 13247268)
1. Comparative efficiency of strophanthin preparations in cardiac disease.
GOTTSEGEN G
Ther Hung; 1954; 3():15-8. PubMed ID: 13247268
[No Abstract] [Full Text] [Related]
2. [Quantitative aspects of strophanthin activity].
STORZ H
Klin Wochenschr; 1958 Feb; 36(3):124-7. PubMed ID: 13540133
[No Abstract] [Full Text] [Related]
3. [Strophanthin K and P-aminobenzoate of diethylammonium in cardiotonic-sedative therapy].
LAMBERTI F
Gazz Med Ital; 1954 Sep; 113(9):272-7. PubMed ID: 13232215
[No Abstract] [Full Text] [Related]
4. [Application of cardiac drugs].
GOMORI P
Orv Hetil; 1951 Mar; 92(13):403-13. PubMed ID: 13046847
[No Abstract] [Full Text] [Related]
5. [Under what conditions strophanthin can be replaced by digitalis].
HOESCH K
Z Gesamte Inn Med; 1955 Jul; 10(13):637-41. PubMed ID: 13257363
[No Abstract] [Full Text] [Related]
6. SELECTION of digitalis preparations and their proper administration.
Am J Med; 1954 Aug; 17(2):271-9. PubMed ID: 13180534
[No Abstract] [Full Text] [Related]
7. Clinical experiences concerning the effect of strophanthin.
FROST J; WARBURG E
Acta Med Scand; 1948; 131(Suppl 206):132-44. PubMed ID: 18881130
[No Abstract] [Full Text] [Related]
8. [Clinical studies on crataegutt-strophanthin & crataegutt].
IMMICH H
Dtsch Med J; 1959 Jan; 10(2):39-42. PubMed ID: 13639731
[No Abstract] [Full Text] [Related]
9. [Clinical experiences with the combination preparation crataegutt-strophanthin].
SCHROER W
Med Monatsschr; 1958 May; 12(5):312-4. PubMed ID: 13551873
[No Abstract] [Full Text] [Related]
10. [Prognostic strophanthin test].
GOTTSEGEN G
Orv Hetil; 1951 Mar; 92(13):413-5. PubMed ID: 13046848
[No Abstract] [Full Text] [Related]
11. [The problem of strophanthin tolerance].
SCHURMEYER A; WILLEMS H
Medizinische; 1956 Sep; 1(35):1178-82. PubMed ID: 13369040
[No Abstract] [Full Text] [Related]
12. [Effect of digitalis on strophanthin refractive heart diseases].
GOTTSEGEN G
Orv Hetil; 1953 May; 94(19):518-21. PubMed ID: 13088014
[No Abstract] [Full Text] [Related]
13. [Clinical experiences with the oral administration of strophanthin G].
MANCINI D; CAPITAINE CACERES R
Dia Med; 1960 Mar; 32():358-60. PubMed ID: 14420506
[No Abstract] [Full Text] [Related]
14. [Miroton as adjuvant for the performance of ambulant strophanthin therapy after dismissal from the hospital & restored compensation].
ANGSTER H
Medizinische; 1958 Jan; 2(2):90-2. PubMed ID: 13516220
[No Abstract] [Full Text] [Related]
15. [Polyclinical treatment of heart disease with cynosid liquidum].
STORCH H
Ther Ggw; 1952 Mar; 91(3):102-4. PubMed ID: 12984383
[No Abstract] [Full Text] [Related]
16. [Strophanthus, digitalis and digitaloids in cardiac therapy. Delimitation of their indications].
SEEL H
Hippokrates; 1959 Oct; 30():702-6. PubMed ID: 14444488
[No Abstract] [Full Text] [Related]
17. Effect of digitalis in patients receiving reserpine.
LOWN B; EHRLICH L; LIPSCHULTZ B; BLAKE J
Circulation; 1961 Nov; 24():1185-91. PubMed ID: 14466974
[No Abstract] [Full Text] [Related]
18. [Theoretical-experimental and clinical fundamentals of peroral strophanthin therapy].
WIESEND W
Ther Umsch; 1956 Sep; 13(9):172-6. PubMed ID: 13380794
[No Abstract] [Full Text] [Related]
19. [The indication of use of pandigal and strophanthin mixed injection].
STEINBERG H
Med Klin; 1954 Jun; 49(23):927-8. PubMed ID: 13164985
[No Abstract] [Full Text] [Related]
20. [Comparative evaluation of the action of corglicon, frugoside and strophanthin in chronic cardiac insufficiency].
POPOVA EA
Sov Med; 1960 Jan; 24():75-80. PubMed ID: 14434143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
